Ginkgo bioworks announces date of fourth quarter and full year 2023 results presentation

Presentation and q&a session scheduled for post-market on thursday, february 29, 2024 boston , feb. 22, 2024 /prnewswire/ -- ginkgo bioworks (nyse: dna), which is building the leading platform for cell programming and biosecurity, today announced that it plans to host a presentation and q&a session reviewing business performance for the fourth quarter and full year ended december 31, 2023, on thursday, february 29, 2024, beginning at 5:30 p.m. et. the presentation details and webcast link will be available on ginkgo's investor relations website at https://investors.ginkgobioworks.com , and a replay will be made available.
DNA Ratings Summary
DNA Quant Ranking